PD CEN TS 16827 — Molecular In Vitro Diagnostic Examinations Specifications for Pre-examination Processes for FFPE Tissue Standard Series

🧬 PD CEN TS 16827 is the British Standards Institution (BSI) Published Document implementing the European Technical Specification CEN/TS 16827, covering pre-examination processes for formalin-fixed paraffin-embedded (FFPE) tissue in molecular in vitro diagnostics (IVD). Prepared by the UK technical committee CH/212 “IVDs” and classified under ICS 11.100.10 (in vitro diagnostic test systems), the series sets standardised pre-examination requirements for RNA, protein, and DNA analysis on FFPE tissue — a key underpinning of tumour molecular pathology, genetic testing, and precision-medicine quality assurance.

💡 In molecular diagnostics, the pre-analytical phase is the largest source of variability affecting result reliability. How FFPE tissue is fixed, dehydrated, embedded, and stored directly determines the quality of nucleic acids and proteins — standardising this process is the prerequisite for reproducible, trustworthy results.

1. Series Structure and Overall Framework 📌

The PD CEN TS 16827 series consists of 3 parts, each targeting one class of analyte extracted from FFPE tissue: RNA, proteins, and DNA. All three share general considerations and terminology for pre-examination, with part-specific requirements for each analyte.

Part	Year	Title	Core Content
PD CEN/TS 16827-1	2015	Isolated RNA	Pre-examination requirements for FFPE tissue used in RNA analysis
PD CEN/TS 16827-2	2015	Isolated proteins	Pre-examination requirements for FFPE tissue used in protein analysis
PD CEN/TS 16827-3	2015	Isolated DNA	Pre-examination requirements for FFPE tissue used in DNA analysis

⚠️ A CEN/TS is a provisional Technical Specification, evaluated after its validity period for possible conversion into an EN. Always reference the current effective version of PD CEN TS 16827 and monitor amendments or re-issue to keep pre-examination aligned with the latest regulation and quality requirements.

2. General Considerations for Pre-examination 🧭

The general-considerations clauses identify the common factors affecting the quality of molecular analysis of FFPE tissue, spanning tissue collection, fixation, dehydration, embedding, sectioning, storage, and nucleic acid/protein extraction:

Fixation and fixation time: the duration and temperature of formalin fixation affect cross-linking, which influences extraction efficiency and integrity of nucleic acids and proteins.
Tissue processing workflow: dehydration, clearing, and paraffin infiltration should be standardised to avoid over-processing that degrades molecules.
Storage conditions: temperature, humidity, and duration of block and section storage must be controlled to prevent molecular deterioration over time.
Extraction and quantitation: extraction methods and purification workflows should be consistent, with yield, purity, and integrity assessed.

The general considerations also stress quality control and record-keeping so that the pre-examination of every FFPE sample is traceable and repeatable.

3. RNA Analysis: Part 1 Requirements 🧪

Part 1 specifies pre-examination requirements for FFPE tissue used for isolated RNA analysis. RNA is the most labile of the nucleic acids, so pre-examination must pay special attention to ribonuclease (RNase) contamination and the effect of fixation conditions on RNA integrity.

Key Step	Requirement
Fixation and deparaffinisation	Control fixation time, standardise deparaffinisation and rehydration to reduce RNase activity
RNA extraction	Use standardised methods, avoiding RNA degradation and genomic DNA contamination
Integrity assessment	Evaluate RNA integrity via RIN or similar metrics as a quality prerequisite for downstream assays
Applications	Gene expression analysis, transcriptome sequencing, fusion-gene detection, etc.

Part 1 also addresses requirements for reverse transcription and pre-amplification, ensuring that RNA obtained from FFPE tissue supports reliable quantitative and qualitative molecular assays.

4. Protein Analysis: Part 2 Requirements 🔬

Part 2 specifies pre-examination requirements for FFPE tissue used for isolated proteins analysis (e.g., immunohistochemistry, proteomics, immunoblotting). Protein cross-linking caused by formalin fixation is the main challenge, requiring appropriate antigen retrieval and protein-extraction strategies.

Key Step	Requirement
Antigen retrieval	Use heat-induced or enzymatic retrieval to unmask cross-linked epitopes
Protein extraction	Standardise extraction buffers and workflows for reliable yield and solubility
Quantitation and storage	Quantify protein concentration and store specimens under controlled conditions to avoid degradation
Applications	Immunohistochemistry, Western blot, mass-spectrometry proteomics, etc.

5. DNA Analysis: Part 3 Requirements 🧫

Part 3 specifies pre-examination requirements for FFPE tissue used for isolated DNA analysis. DNA is comparatively stable, but fixation and processing still cause cross-linking and fragmentation that affect long-fragment PCR and sequencing quality.

Key Step	Requirement
Fixation and deparaffinisation	Control fixation conditions, standardise deparaffinisation to release high-quality DNA
DNA extraction	Standardise extraction methods, assess purity and fragment-size distribution
Degradation and cross-link assessment	Evaluate DNA amplifiability by PCR or quantitative methods; decide whether cross-link repair is needed
Applications	Mutation detection, methylation analysis, next-generation sequencing (NGS), etc.

✅ The three parts form a complete pre-examination specification for FFPE tissue: RNA focuses on degradation control, proteins on antigen retrieval, and DNA on cross-linking and fragmentation — together ensuring reliable, repeatable downstream molecular assays.

6. Engineering Practice and Application Notes 🛠️

🔍 End-to-end sample management: every step from collection, fixation, embedding to extraction should follow standard operating procedures (SOPs) with records for traceability.
🔧 Quality-control indicators: use nucleic-acid integrity, protein yield, and purity as release criteria; re-test or re-sample non-conforming specimens.
📊 Alignment with molecular assays: pre-examination specifications should pair with downstream methods (PCR, sequencing, IHC) to form a whole-chain quality system.
📋 Regulatory compliance: IVD-related requirements should be aligned with the EU IVDR and UK regulations, accounting for the impact of pre-examination on clinical results.

7. Frequently Asked Questions ❓

❓ Q: Why specify pre-examination processes for FFPE tissue separately?
A: FFPE is the most common tissue-preservation method in pathology, but fixation and embedding alter the chemical properties of nucleic acids and proteins; standardising pre-examination is key to reliable molecular results.

❓ Q: How does pre-examination differ for RNA versus DNA?
A: RNA is more labile and demands strict control of RNase contamination and fixation time; DNA is more stable but prone to cross-linking and fragmentation, so amplifiability must be assessed. Extraction and QC strategies differ accordingly.

❓ Q: What is the relationship between pre-examination and examination (test method) specifications?
A: Pre-examination precedes the examination method; together they form the complete molecular workflow. Standardising pre-examination is a prerequisite for valid method results.

🔍 Q: Why is this series published as PD rather than an EN?
A: Because it is the UK implementation of a CEN/TS technical specification of provisional application, subject to evaluation before promotion; BSI adopts and publishes it as a Published Document.

🔒

正在加载下载地址，请稍候 10 秒